Gian Life Care Limited
Fixed Price Issue IPO · BSE
- Price band
- ₹22 - ₹22
- Lot size
- 6,000 shares
- Issue amount
- ₹3 cr
- Total subscription
- 0×
- Opens
- 31 Dec 2019
- Closes
- 3 Jan 2020
- Allotment
- 8 Jan 2020
- Listing
- 13 Jan 2020
Offer at a glance
Issue overview
- Issue size
- 14,16,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,32,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Cameo Corporate Services Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,32,000
- Issue type
- Fixed Price Issue IPO
- Shares before issue
- 32,84,694
- Shares after issue
- 47,00,694
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 6,000 | ₹1,32,000 |
| HNI | 2 | 12,000 | ₹2,64,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Gian Life Care Limited, founded in 2018 and based in Kanpur, Uttar Pradesh, is a diagnostic and healthcare service provider offering a wide range of tests and health services focused on diagnosis, prevention, and wellness for individuals as well as hospitals and corporate clients. The company provides over 1,344 diagnostic tests covering areas such as biochemistry, clinical pathology, hematology, histopathology, microbiology, molecular biology, immunoassay, cytogenetics, cytology, coagulation, and radiology. Gian Life Care operates as an NABL accredited and ISO 9001:2015 certified organization and is supported by a team of 59 full-time employees.
Strengths
- Wide diagnostic test portfolio: Provides over 1,344 diagnostic tests covering pathology, molecular biology, cytogenetics, radiology, and preventive healthcare.
- Quality accreditations and certifications: NABL accreditation and ISO 9001:2015 certification enhance credibility and service reliability.
- Diverse client base: Serves individuals, hospitals, and corporate clients, reducing dependence on a single customer segment.
Risk factors
- Limited operating history: Incorporated in 2018, the company has a relatively short track record compared to established diagnostic chains.
- Smaller workforce scale: Supported by 59 full-time employees, which may limit rapid expansion and operational scalability.
- Geographical concentration: Operations are primarily based in and around Uttar Pradesh, restricting national-level presence.
Promoters
Mr. Arun Kumar Gupta
Registrar & documents
Lead manager
Hem Securities Limited
Registrar & contacts
Cameo Corporate Services Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
7/216 (6), Swaroop Nagar, Kanpur-208002
91-0512-2531860
[email protected]Company website ↗Understanding GIANLIFE IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.